Growth Metrics

Palisade Bio (PALI) Assets Average (2016 - 2025)

Palisade Bio has reported Assets Average over the past 15 years, most recently at $70.7 million for Q4 2025.

  • Quarterly Assets Average rose 599.04% to $70.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.7 million through Dec 2025, up 599.04% year-over-year, with the annual reading at $72.6 million for FY2025, 482.48% up from the prior year.
  • Assets Average was $70.7 million for Q4 2025 at Palisade Bio, up from $6.8 million in the prior quarter.
  • Over five years, Assets Average peaked at $70.7 million in Q4 2025 and troughed at $6.0 million in Q1 2021.
  • The 5-year median for Assets Average is $12.4 million (2022), against an average of $15.1 million.
  • The largest YoY upside for Assets Average was 599.04% in 2025 against a maximum downside of 41.79% in 2025.
  • A 5-year view of Assets Average shows it stood at $14.4 million in 2021, then grew by 11.27% to $16.0 million in 2022, then decreased by 2.84% to $15.6 million in 2023, then crashed by 35.04% to $10.1 million in 2024, then skyrocketed by 599.04% to $70.7 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Assets Average are $70.7 million (Q4 2025), $6.8 million (Q3 2025), and $7.4 million (Q2 2025).